• 主页
  • 查找结果
  • Vitamin D binding protein and vitamin D in human allergen-induced endobronchial inflammation.

Vitamin D binding protein and vitamin D in human allergen-induced endobronchial inflammation.

Clinical and experimental immunology (2014-04-16)
K Bratke, A Wendt, K Garbe, M Kuepper, P Julius, M Lommatzsch, J C Virchow
摘要

Allergic asthma is a chronic disease of the airways associated with airway hyperresponsiveness, a variable degree of airflow obstruction, airway remodelling and a characteristic airway inflammation. Factors of the vitamin D axis, which include vitamin D metabolites and vitamin D binding protein (VDBP), have been linked to asthma, but only few data exist about their regulation in the lung during acute allergen-induced airway inflammation. Therefore, we analysed the regulation of factors of the vitamin D axis during the early- and late-phase reaction of allergic asthma. Fifteen patients with mild allergic asthma underwent segmental allergen challenge. VDBP was analysed in bronchoalveolar lavage fluid (BALF) and serum using the enzyme-linked immunosorbent assay (ELISA) technique. 25-hydroxyvitamin D(3)[25(OH)D(3)] and 1,25-dihydroxyvitamin D(3)[1,25(OH)(2)D(3)] were analysed by a commercial laboratory using the liquid chromatography-mass spectrometry (LC/MS) technique. VDBP (median 2·3, range 0·2-7·1 μg/ml), 25(OH)D(3) (median 0·060, range < 0·002-3·210 ng/ml) and 1,25(OH)(2)D(3) (median < 0·1, range < 0·1-2·8 pg/ml) were significantly elevated in BALF 24 h but not 10 min after allergen challenge. After correction for plasma leakage using the plasma marker protein albumin, VDBP and 25(OH)D(3) were still increased significantly while 1,25(OH)(2)D(3) was not. VDBP and 25(OH)D(3) were correlated with each other and with the inflammatory response 24 h after allergen challenge. Serum concentrations of all three factors were not influenced by allergen challenge. In conclusion, we report a significant increase in VDBP and 25(OH)D(3) in human BALF 24 h after allergen challenge, suggesting a role for these factors in the asthmatic late-phase reaction.

材料
货号
品牌
产品描述

Sigma-Aldrich
1α,25-二羟基维生素D3, ≥99% (HPLC)
Supelco
25-羟基维生素D3标准液 CRM 溶液, 100 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
25-羟基胆钙化醇, ≥98% (HPLC)
Sigma-Aldrich
1α,25-二羟基维生素D3, ≥97.0% (HPLC)
Supelco
1α,25-二羟基维生素D3标准液 CRM 溶液, 5 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
3--25-羟基维生素 D3, 98% (CP)
Supelco
25-羟基维生素D3标准液 CRM 溶液, 5 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
骨化三醇, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Anti-Vitamin D-Binding Protein antibody produced in chicken, affinity isolated antibody, buffered aqueous solution

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。